4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)
    Meeting Abstract

    Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors
    Meeting Abstract

    Bauer, T. M.; Chae, Y. K.; Patel, S.; D'Angelo, S. P.; Blumenschein, G. R.; Norton, J.; Pound, C.; Lanasa, M. C.; Curti, B. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)
    Meeting Abstract

    Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase III trial of carboplatin/paclitaxel alone (CP) or in combination with bevacizumab followed by bevacizumab (CPB) and secondary cytoreduction surgery in platinum-sensitive recurrent ovarian cancer: GOG0213, an NRG Oncology/GOG Study-Analysis of patient reported outcomes (PRO) on chemotherapy randomization
    Meeting Abstract

    Basen-Engquist, K.; Huang, H. Q.; Herzog, T. J.; Armstrong, D. K.; Sabbatini, P.; Walker, J. L.; Kim, B. G.; Fujiwara, K.; Tewari, K. S.; O'Malley, D. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA mutant tumors
    Meeting Abstract

    Baselga, J.; Cortes, J.; De Laurentiis, M.; Dieras, V.; Harbeck, N.; Im, Y. H.; Jacot, W.; Krop, I. E.; Verma, S.; Wilson, T. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials
    Meeting Abstract

    Barrientos, J. C.; Ghia, P.; Pagel, J.; Salles, G. A.; Sharman, J. P.; Stilgenbauer, S.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma
    Meeting Abstract

    Bambury, R. M.; Jordan, E.; Zabor, E. C.; Bouvier, N.; Al-Ahmadie, H.; Boyd, M. E.; Mullane, S. A.; Cha, E. K.; Ostrovnaya, I.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Molecular profiling of pancreatic adenocarcinoma to identify targeted therapeutic options in patients who have undergone pancreaticoduodenectomy
    Meeting Abstract

    Baker, E. H.; Fruscione, M.; Cochran, A.; Millis, S. Z.; Martinie, J. B.; Swan, R. Z.; Iannitti, D. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy
    Meeting Abstract

    Bajorin, D. F.; Plimack, E. R.; Siefker-Radtke, A. O.; Choueiri, T. K.; De Wit, R.; Sonpavde, G.; Gipson, A.; Brown, H.; Mai, Y. B.; Pang, L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Comparison between clinician- and patient-reporting of baseline (BL) and post-BL symptomatic toxicities in cancer cooperative group clinical trials (NCCTG N0591 [Alliance])
    Meeting Abstract

    Atkinson, T. M.; Satele, D. V.; Sloan, J. A.; Mehedint, D.; Lafky, J. M.; Basch, E. M.; Dueck, A. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save